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INTRODUCTION {#bem21987-sec-0002}
============

Sensitivity to electromagnetic fields (EMFs) has generally been referred to as "electromagnetic hypersensitivity (EHS)," whereas the scientific term for this phenomenon is "idiopathic environmental intolerances attributed to electromagnetic fields (IEI‐EMFs)" \[WHO, [2005](#bem21987-bib-0038){ref-type="ref"}; COST, [2011](#bem21987-bib-0005){ref-type="ref"}\]. We have used the term "EHS" throughout this paper because it was used by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\] in the originally developed questionnaire. The questionnaire was subsequently translated to Japanese and has been used as the Japanese version of Eltiti\'s questionnaire in the present study.

EHS is characterized by a variety of non‐specific symptoms, which affected individuals have attributed to exposure to EMFs \[WHO, [2005](#bem21987-bib-0038){ref-type="ref"}\]. Health effects of exposure to strong EMFs are well‐documented, and are generally controlled by regulations and guidelines \[ICNIRP, [2009](#bem21987-bib-0019){ref-type="ref"}\]. In addition, numerous reports exist on health effects of low‐level EMF exposure \[Hillert et al., [2002](#bem21987-bib-0009){ref-type="ref"}; Mohler et al., [2010](#bem21987-bib-0028){ref-type="ref"}; Röösli et al., [2010](#bem21987-bib-0032){ref-type="ref"}; Rubin et al., [2010](#bem21987-bib-0033){ref-type="ref"}; Baliatsas et al., [2012](#bem21987-bib-0002){ref-type="ref"}\]. However, there has not been, until now, conclusive evidence linking the pathophysiology of EHS to any previous exposure to EMFs \[WHO, [2005](#bem21987-bib-0038){ref-type="ref"}; COST, [2011](#bem21987-bib-0005){ref-type="ref"}\]. There is also evidence of a "nocebo effect" in triggering acute health reactions \[Rubin et al., [2011](#bem21987-bib-0034){ref-type="ref"}; Witthöft and Rubin, [2013](#bem21987-bib-0039){ref-type="ref"}\]. Moreover, other factors, including poor indoor air quality or stress in the workplace/living environment, may also play significant roles \[WHO, [2005](#bem21987-bib-0038){ref-type="ref"}\].

A very wide range (1.2--13.3%) of estimates exists regarding the prevalence of EHS in the general population \[Meg Tseng et al., [2001](#bem21987-bib-0026){ref-type="ref"}; Hillert et al., [2002](#bem21987-bib-0009){ref-type="ref"}; Levallois et al., [2002](#bem21987-bib-0025){ref-type="ref"}; Leitgeb and Schröttner, [2003](#bem21987-bib-0024){ref-type="ref"}; Schreier et al., [2006](#bem21987-bib-0035){ref-type="ref"}; Preece et al., [2007](#bem21987-bib-0030){ref-type="ref"}; Landgrebe et al., [2008](#bem21987-bib-0023){ref-type="ref"}; Schröttner and Leitgeb, [2008](#bem21987-bib-0036){ref-type="ref"}; Mohler et al., [2010](#bem21987-bib-0028){ref-type="ref"}; Röösli et al., [2010](#bem21987-bib-0032){ref-type="ref"}; Rubin et al., [2010](#bem21987-bib-0033){ref-type="ref"}, [2011](#bem21987-bib-0034){ref-type="ref"}; Baliatsas et al., [2012](#bem21987-bib-0002){ref-type="ref"}; Hojo and Tokiya, [2012](#bem21987-bib-0018){ref-type="ref"}; Nordin et al., [2013](#bem21987-bib-0029){ref-type="ref"}\]. In Japan, Furubayashi et al. \[[2009](#bem21987-bib-0008){ref-type="ref"}\] reported that 1.2% of females showed mobile phone‐related and other unusual symptoms around telecommunication masts; however, further reports concerning EHS among the Japanese population are lacking. As well, the number of people with an EHS condition varies between countries. This may be attributed to differences in the definitions of EHS, the methods of assessment used, and media coverage during the survey \[COST, [2011](#bem21987-bib-0005){ref-type="ref"}\].

The lack of a general case definition for EHS, and the absence of a standardized approach for measuring concrete aspects of EHS that would permit a cross‐comparison by different investigators, have delayed further studies in this area. Surveys using conventional psychological tests or questions with "yes" or "no" answers have been the most commonly used measures for the evaluation of effects of EMFs on health \[Abdel‐Rassoul et al., [2007](#bem21987-bib-0001){ref-type="ref"}, Berg‐Beckhoff et al., [2009](#bem21987-bib-0003){ref-type="ref"}; Blettner et al., [2009](#bem21987-bib-0004){ref-type="ref"}\]. However, investigations using conventional questionnaires failed to reveal any specific symptoms of EHS, nor clarified the severity of symptoms associated with exposure to specific EMF objects.

In the United Kingdom (UK), Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\] developed the EHS questionnaire, which evaluates effects of EMF exposure, particularly on EMF‐related health conditions.

The main advantage of this EHS questionnaire is that it not only takes into account the individual\'s belief as to the cause of their symptom(s), but also includes the degree of symptom severity. The study reported that 145 (4.0%) out of 3,633 respondents from a randomly selected general population of 20,000 people met the "screening criteria for EHS." Subsequently, we translated "Eltiti\'s questionnaire" into Japanese by modifying and adding several questions unique to the Oita version of the Japanese EHS questionnaire, which was confirmed for its validity and reliability, and was used for investigating health effects of EMFs from mobile phone base stations on 520 members of a randomly selected general public (230 males, 20--89 years old; and 290 females, 18--87 years old) in Oita Prefecture, Japan in 2010.

In the past, we \[Hojo, [2002](#bem21987-bib-0010){ref-type="ref"}; Hojo et al., [2003](#bem21987-bib-0011){ref-type="ref"}, [2004](#bem21987-bib-0012){ref-type="ref"}, [2005](#bem21987-bib-0013){ref-type="ref"}, [2007](#bem21987-bib-0014){ref-type="ref"}, [2008a](#bem21987-bib-0015){ref-type="ref"}, [2008b](#bem21987-bib-0016){ref-type="ref"}, [2009](#bem21987-bib-0017){ref-type="ref"}; Hojo and Tokiya, [2012](#bem21987-bib-0018){ref-type="ref"}\] conducted several investigations in order to elucidate the actual status of multiple chemical sensitivity (MCS) and sick building syndrome or sick house syndrome (SHS) patients in Japan using the quick environmental exposure and sensitivity inventory (QEESI) developed by Miller and Prihoda \[[1999](#bem21987-bib-0027){ref-type="ref"}\]. Our findings revealed that a number of MCS/SHS patients complained of hypersensitive reactions to various EMF sources. We have, therefore, been on the lookout for a questionnaire that can evaluate hypersensitive reactions to sources of EMFs in order to assess the genuineness or spuriousness of patients' complaints. However, the above‐mentioned "Oita version of Japanese EHS questionnaire" was not used, because it had been significantly modified from the original one \[Eltiti et al., [2007](#bem21987-bib-0007){ref-type="ref"}\]. Therefore, in this study, we accurately re‐translated Eltiti\'s questionnaire, and subsequently developed a new Japanese version (Japanese EHS questionnaire), courtesy of Dr. S. Eltiti.

The aims of the present study were as follows: (1) to evaluate the reliability and validity of the Japanese EHS questionnaire; (2) to reveal characteristics of symptoms in Japanese self‐selected EHS subjects; (3) to reveal characteristics of EMF objects that Japanese self‐selected EHS subjects believed were the cause of their EHS‐related symptoms and reactions; (4) to reveal characteristics of chronic illnesses (past and present) in Japanese self‐selected EHS subjects; and (5) to propose preliminary criteria for the screening of EHS individuals in Japan on the basis of the findings of this study.

METHODS {#bem21987-sec-0003}
=======

Structure of the Japanese EHS Questionnaire {#bem21987-sec-0004}
-------------------------------------------

The Japanese EHS questionnaire consisted of four sections: (I) biographical information; (II) symptoms and causes; (III) general health data; and (IV) additional questions unique to the Japanese questionnaire. Sections I, II, and III were almost identical to those in the original EHS questionnaire \[Eltiti et al., [2007](#bem21987-bib-0007){ref-type="ref"}\] in terms of the content of questions and the manner in which participants were required to answer them. Some parts of questions were slightly modified after consultation with MCS/EHS specialists, based on specific needs of the Japanese population.

### Biographical information {#bem21987-sec-0005}

In this section, the participants were asked six questions regarding their age, gender, address, occupation, final academic background, and mean working hours per day.

### Symptoms and causes (q1--71) {#bem21987-sec-0006}

#### Symptoms (q1--57) {#bem21987-sec-0007}

In this section, participants were questioned about the frequency of occurrence of 57 symptoms (Supplementary Table). They were required to indicate their responses using a 5‐point scale: 1 (not at all), 2 (a little bit), 3 (moderately), 4 (quite a bit), and 5 (a great deal). It should be noted that symptoms were presented as single words or phrases in the EHS questionnaire used by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\], whereas in the Japanese version, symptoms were presented in the form of questions (Supplementary Table).

#### EMF‐producing objects (q58--66) {#bem21987-sec-0008}

In this section, nine questions were asked regarding the perception of a link between EMF‐producing objects and 57 symptoms. Participants needed to indicate their responses using the 5‐point scale described earlier. Furthermore, each participant was asked to write the name of an object and the severity of the symptom, in order to ascertain the presence of any additional EMF objects that were not mentioned in the EHS questionnaire used by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\].

#### Reactions to EMF exposure (q67--71) {#bem21987-sec-0009}

In this section, participants were required to answer three questions regarding EMF sensitivity (q67), occurrence of static shocks (q70), and negative health changes around EMFs (q71) using the 5‐point scale. Moreover, in order to determine if there were any additional EMF‐producing objects that were not mentioned in the original EHS questionnaire \[Eltiti et al., [2007](#bem21987-bib-0007){ref-type="ref"}\], participants were required to state specific EMF object(s) affecting their health, along with a detailed description of symptom(s) experienced (q68, a descriptive‐type question). Participants were also asked to indicate if they had ever experienced severe electric shock (q69, a "yes" or "no" question).

### General health (1--4) {#bem21987-sec-0010}

In this section, questions 1 to 3--1 and 4 were identical to those in the EHS questionnaire \[Eltiti et al., [2007](#bem21987-bib-0007){ref-type="ref"}\]. However, in order to evaluate the quality of sleep, participants were questioned about average sleeping hours (3--2), and quality of sleep (3--3, sleep disorder; Japanese modification; Supplementary Materials).

### Additional questions unique to the Japanese questionnaire {#bem21987-sec-0011}

#### The todai health index‐depression (THI‐D) scale (10 items) {#bem21987-sec-0012}

The THI‐D scale is frequently used to assess symptoms of depression in Japan \[Takeuchi et al., [1994](#bem21987-bib-0037){ref-type="ref"}; Kawada et al., [1999](#bem21987-bib-0022){ref-type="ref"}\]. Results of the THI‐D scale in the present study were compared with those of existing health surveys that have used this method in Japan because most self‐selected EHS subjects generally develop symptoms of depression.

#### Physician‐diagnosed chronic illness (present and past) {#bem21987-sec-0013}

In order to determine the relationship between EHS and other chronic illnesses, including MCS and SHS, participants were provided with a list of chronic illnesses and asked to mark their current illness with a circle within a circle (⊚), and their past chronic illnesses with a circle only (○).

#### Sequence of EHS development {#bem21987-sec-0014}

Participants who believed that they had developed EHS or MCS were asked to answer questions regarding the time and sequence of onset of EHS, MCS, and SHS (Supplementary Materials).

STUDY PERIOD AND PARTICIPANTS {#bem21987-sec-0015}
=============================

Surveys were conducted between 2009 and 2015.

Controls {#bem21987-sec-0016}
--------

The control group was comprised of ordinary residents living in cities across Japan. Participants exhibited a wide age range, and were recruited via mailing lists and information magazines using universities and local non‐profit organizations (NPOs) as contacts. The questionnaire was mailed to 2,000 selected persons, with 1,320 questionnaires returned (participation rate, 66%). However, valid data (data concerning age, sex, and at least 90% other entries) were obtained from only 1,306 of the 1,320 returned questionnaires.

Self‐Selected EHS Subjects {#bem21987-sec-0017}
--------------------------

Self‐selected EHS subjects were recruited via two self‐help EHS groups in Japan. Questionnaires were mailed to 165 people who cooperated with our research, and were returned from 128 patients (participation rate, 77.6%). However, valid data were obtained from only 127 patients as one patient complained of MCS symptoms and was, therefore, excluded from the study.

Statistical Analyses {#bem21987-sec-0018}
--------------------

Statistical analyses were performed using SPSS for Windows (version 22; IBM, Armonk, NY).

### Reliability {#bem21987-sec-0019}

Test--retest measures were applied to 52 NPO members (males: *n* = 27, average age: 48.93 ± 16.70 years; females: *n* = 25, average age: 42.76 ± 14.75 years) and 121 students from three universities (males: *n* = 38, average age: 20.00 ± 0.62 years; females: *n* = 83, average age: 20.83 ± 0.91 years). Thus, a total of 173 subjects from the general public (males: *n* = 65, average age: 32.02 ± 17.89 years, age range: 19--76; females: *n* = 108, average age: 25.91 ±11.65 years, age range: 17*--*66) were included for test--retest measures. The same test was performed twice in 1--2‐week intervals by the same subjects. The score obtained for each question, using the 5‐point scale, and the total score from each subscale were determined by intraclass correlation coefficients (ICC). The Kappa (*κ*) coefficient was calculated for q68 and q69 due to dichotomous response options ("yes" or "no") for these questions. Internal consistency was calculated using Cronbach\'s *α* coefficient \[Cronbach, [1951](#bem21987-bib-0006){ref-type="ref"}\] for each subscale in questionnaires obtained from controls and self‐selected EHS subjects.

### Validity {#bem21987-sec-0020}

Discrimination validity of the Japanese questionnaire was determined by comparing scores of each question and total scores for each subscale between self‐selected EHS subjects (*n* = 127), and sex‐ and age‐matched (±5 years) controls (*n* = 127), using bivariate logistic regression analyses, Mann--Whitney *U*‐ and *χ* ^2^ tests, and with Bonferroni correction for multiple tests (100 tests; *P* \< 0.0005).

Furthermore, the distribution pattern of total symptom scores concerning 57 symptoms in both groups is depicted using a histogram (Fig. [1](#bem21987-fig-0001){ref-type="fig"}a) and box‐and‐whisker plots (Fig. [1](#bem21987-fig-0001){ref-type="fig"}b). The 25th, 50th, and 75th percentiles were estimated for scores of total symptoms in the control group. The horizontal line in each box represents the median value, whereas those at the bottom and top of the box represent 25th and 75th percentile values, respectively. The median score of total symptoms in self‐selected EHS subjects was compared with that of controls using a Mann--Whitney *U*‐test (Fig. [1](#bem21987-fig-0001){ref-type="fig"}a and b) with Bonferroni correction for multiple tests (100 tests; *P* \< 0.0005). Median values of symptoms (eight principal components) are shown in a radar chart (Fig. [1](#bem21987-fig-0001){ref-type="fig"}c).

![Comparison of total symptom scores between controls and self‐selected EHS subjects. **1a**. Histogram showing total symptom scores. EHS: electromagnetic hypersensitivity. **1b**. Box‐and‐whisker plots showing total symptom scores. Plots inside ellipse represent outliers that are not within normal range. Note: differences in median scores of total symptoms between self‐selected EHS subjects (*n* = 127) and controls (*n* = 127) were compared using a Mann--Whitney *U*‐test with Bonferroni correction for multiple tests (100 tests; *P* \< 0.0005); \*\*\**P* ≤ 0.00001. For **1a** and **1b**: The ^a^25th percentile (16 points), ^b^50th percentile (29 points), and ^c^75th percentile value of controls (47 points). **1c**. Radar chart showing median values of symptoms for eight principal components (factors 1--8). Differences in median values of symptoms for all eight principal components between self‐selected EHS subjects (*n* = 127) and controls (*n* = 127) were analyzed using a Mann--Whitney *U*‐test as above. There were significant differences (*P* ≤ 0.00001) in median values of symptoms for all eight principal components.](BEM-37-353-g001){#bem21987-fig-0001}

### Preliminary screening criteria for EHS individuals {#bem21987-sec-0021}

Multiple logistic regression and receiver operating characteristic (ROC) analyses were implemented between the self‐selected EHS subject group (*n* = 127) and the sex‐ and age‐matched control group (*n* = 127); preliminary screening criteria for EHS individuals from the general population were calculated using results of these analyses.

Ethical Considerations {#bem21987-sec-0022}
----------------------

The present study was approved by the ethics committees of the following institutes in Japan: Oita University (approved on June 4, 2009); National Hospital Organization (NHO), Morioka National Hospital, Morioka (approved on June 6, 2012); and NHO, Sagamihara National Hospital, Sagamihara (approved on July 9, 2013), in accordance with the Declaration of Helsinki \[WMA, [2013](#bem21987-bib-0040){ref-type="ref"}\].

RESULTS {#bem21987-sec-0023}
=======

Sample Characteristics {#bem21987-sec-0024}
----------------------

Table [1](#bem21987-tbl-0001){ref-type="table-wrap"} shows characteristics of controls and self‐selected EHS subjects. Mean working hours of EHS patients (6.52 h) were significantly lower than those of controls (8.42 h). There were no significant differences in resident area and final academic background between self‐selected EHS subjects, and age‐ and sex‐matched controls. On the other hand, there were significantly fewer full‐time workers and more unemployed persons among self‐selected EHS subjects when compared with controls.

###### 

Characteristics of Controls and Self‐Selected EHS Subjects

                                                                             Controls (total) (*n* = 1306)   Controls (met set screening criteria[^a^](#bem21987-note-0003){ref-type="fn"}) (*n* = 60)   Controls (age and sex matched) (*n* = 127)   Self‐selected EHS subjects (*n* = 127)   *χ* ^2^ test *P* value
  -------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------------------------------------- -------------------------------------------- ---------------------------------------- --------------------------------------------------------
  Biographical information                                                                                                                                                                                                                                                                     
  Gender                                                                                                                                                                                                                                                                                       
  Male                                                                       373 (28.6%)                     10 (16.7%)                                                                                  26 (20.5%)                                   26 (20.5%)                               1.000 n.s.
  Female                                                                     933 (71.4%)                     50 (83.3%)                                                                                  101 (79.5%)                                  101 (79.5%)                              
  Total                                                                      1306 (100%)                     60 (100%)                                                                                   127 (100%)                                   127 (100%)                               
  Age (years)                                                                                                                                                                                                                                                                                  
  19≧                                                                        144 (11.0%)                     4 (6.7%)                                                                                    3 (2.4%)                                     4 (3.1%)                                 0.977 n.s.
  20--39                                                                     491 (37.6%)                     22 (36.7%)                                                                                  9 (7.1%)                                     8 (6.3%)                                 
  40--50                                                                     424 (32.5%)                     20 (33.3%)                                                                                  68 (53.5%)                                   68 (53.5%)                               
  60≦                                                                        247 (18.9%)                     14 (23.2%)                                                                                  47 (37.0%)                                   47 (37.0%)                               
  Total                                                                      1306 (100%)                     60 (100%)                                                                                   127 (100%)                                   127 (100%)                               
  Mean ± SD                                                                  40.49 ± 18.00                   43.10 ± 17.03                                                                               54.28 ± 13.87                                54.35 ± 14.34                            
  Area                                                                                                                                                                                                                                                                                         
  Hokkaido/Tohoku[^b^](#bem21987-note-0004){ref-type="fn"}                   602 (46.6%)                     31 (51.7%)                                                                                  6 (4.7%)                                     6 (4.7%)                                 
  Kantou/Koussin/Hokuriku[^c^](#bem21987-note-0005){ref-type="fn"}           232 (18.0%)                     9 (15.0%)                                                                                   51 (40.2%)                                   54 (42.5%)                               0.941 n.s.
  Tokai/Kinki/Chugoku[^d^](#bem21987-note-0006){ref-type="fn"}               286 (22.1%)                     11 (18.3%)                                                                                  54 (42.5%)                                   54 (42.5%)                               
  Kyushu/Shikoku/Okinawa[^e^](#bem21987-note-0007){ref-type="fn"}            172 (13.3%)                     9\. (15.0%)                                                                                 16 (12.6%)                                   13 (10.2%)                               
  Education                                                                                                                                                                                                                                                                                    
  Primary school                                                             17 (1.4%)                       2 (3.4%)                                                                                    5 (4.1%)                                     3 (2.4%)                                 0.113 n.s.
  High school                                                                610 (50.1%)                     21(35.6%)                                                                                   47 (38.5%)                                   32 (25.6%)                               
  College/University                                                         530 (43.5%)                     30 (50.8%)                                                                                  65 (53.3%)                                   82 (65.6%)                               
  Graduate                                                                   60 (4.9%)                       6 (10.2%)                                                                                   5 (4.1%)                                     8 (6.4%)                                 
  Total                                                                      1217 (100%)                     59 (100%)                                                                                   122 (100%)                                   125 (100%)                               
  Occupation                                                                                                                                                                                                                                                                                   
  Unemployed                                                                 127 (11.1%)                     4 (6.8%)                                                                                    16 (13.1%)                                   42 (33.9%)                               
  Student                                                                    171 (14.9%)                     16 (29.1%)                                                                                  6 (4.9%)                                     4 (3.2%)                                 
  Homeworker                                                                 184 (16.0%)                     7 (11.9%)                                                                                   22 (16.4%)                                   37 (29.8%)                               4.59 × 10^−6^ [\*](#bem21987-note-0009){ref-type="fn"}
  Part‐time worker                                                           178 (15.5%)                     7 (11.9%)                                                                                   26 (21.3%)                                   16 (12.9%)                               
  Full‐time worker                                                           489 (42.5%)                     25 (42.4%)                                                                                  54 (49.6%)                                   25 (20.2%)                               
  Total                                                                      1149 (100%)                     59 (100%)                                                                                   122 (100%)                                   124 (100%)                               
  Mean working hours per day[^f^](#bem21987-note-0008){ref-type="fn"} ± SD   8.21 ± 3.57                     9.06 ± 3.16                                                                                 8.42 ± 3.57                                  6.52 ± 3.38                              6.25 × 10^−5^ [\*](#bem21987-note-0009){ref-type="fn"}

Note: Differences in scores between groups were analyzed by *χ* ^2^ tests with Bonferroni correction for multiple tests (100 tests; *P* \< 0.0005).

EHS, electromagnetic hypersensitivity; SD, standard deviation; n.s., not significant.

Controls met set screening criteria for EHS: controls who met set screening criteria for EHS individuals.

Hokkaido/Tohoku: seven prefectures (e.g., Hokkaido, Aomori, Iwate, Miyagi, Akita, Yamagata, Fukushima).

Kantou/Koussin/Hokuriku: thirteen prefectures (e.g., Ibaraki, Tochigi, Gunma, Saitama, Chiba, Tokyo, Kanagawa, Niigata, Toyama, Ishikawa, Fukui, Yamanashi, Nagano).

Tokai/Kinki/Chugoku: thirteen prefectures (e.g., Gifu, Shizuoka, Aichi, Mie, Shiga, Kyoto, Osaka, Hyogo, Nara, Wakayama, Tottori, Shimane, Okayama, Hiroshima, Yamaguchi).

Kyushu/Shikoku/Okinawa: twelve prefectures (e.g., Tokushima, Kagawa, Ehime, Kochi, Fukuoka, Saga, Nagasaki, Kumamoto, Oita, Miyazaki, Kagoshima, Okinawa).

Mean working hours per day: included housework and school hours.

*P* ≤ 0.00001.

© 2016 Wiley Periodicals, Inc.

Principal Component Analysis {#bem21987-sec-0025}
----------------------------

Firstly, an exploratory principal component analysis (PCA) of 57 symptoms was carried out on controls (*n* = 1,306), using direct oblimin rotation, in order to examine the underlying pattern of symptoms and to condense their total number. Direct oblimin rotation was chosen over the usual varimax rotation owing to the viewpoint that this allows for components to be correlated to one another. Components with a factor loading over 0.4 were chosen, resulting in 12 components with eigenvalues greater than one, and accounting for 59.3% of the variance. Next, evaluation of the scree plot revealed only one component above the marked elbow, indicating that the first component accounted for 28.79% of the variance. However, owing to the complex nature of EHS and the lack of information regarding the pattern of EHS symptoms, we deemed it more appropriate to examine several multivariate solutions. The present study was aimed at developing a measure that could be used to explore specific aspects of EHS; therefore, we looked for several forced factor solutions (10‐, 9‐, 8‐, 7‐, and 6‐factor) with direct oblimin rotation. A forced eight‐factor solution was chosen for the following five reasons: (1) it contained the least number of cross‐loaded items; (2) it also had the highest number of items loaded onto each component; (3) the items that loaded onto each component resulted in cohesive symptom categories; (4) it was able to account for 51.9% of the variance; and (5) the same analysis was used in the study by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\]. Table [2](#bem21987-tbl-0002){ref-type="table-wrap"} illustrates eight categories that were revealed following further inspection of items within each component: nervous (10 items), skin‐related (8 items), head‐related (7 items), auditory and vestibular (8 items), musculoskeletal (8 items), allergy‐related (6 items), sensory (4 items), and heart/chest‐related (6 items). Factor loadings resulted in a high value of over 0.4 (0.406--0.881) with the exception of two symptoms, blisters on the skin (0.379) and high blood pressure (0.387). An eight‐factor principal component analysis was implemented in 246 people who presented with "q67 ≥ 1 point" in the general population (EHS group), in the same way as reported by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\]. Finally, eight‐factor principal component analysis was attempted in 127 self‐selected EHS subjects. As a result, principal components were almost consistent with those of the entire general population (Table [3](#bem21987-tbl-0003){ref-type="table-wrap"}).

###### 

Factor Loadings From Forced Eight‐Factor Principal Component Analysis of Controls (*n* = 1306)

  Principal components        1                                  2              3              4                     5                  6                 7           8                     
  --------------------------- ---------------------------------- -------------- -------------- --------------------- ------------------ ----------------- ----------- --------------------- -----------
  Symptoms                    Nervous                            Skin‐related   Head‐related   Auditory vestibular   Musculo‐skeletal   Allergy‐related   Sensory     Heart/chest‐related   
  Eigenvalue                  16.41                              2.77           2.22           2.08                  1.58               1.53              1.52        1.32                  
  Proportion (%)              28.79                              4.85           3.89           3.64                  2.76               2.68              2.67        2.31                  
  Cumulative proportion (%)   28.79                              33.64          37.53          41.17                 43.93              46.61             49.28       51.59                 
  q12                         Depression                         **0.811**      0.190          ‐0.363                0.302              ‐0.245            0.241       0.263                 0.371
  q13                         Difficulty in concentrating        **0.806**      0.219          ‐0.347                0.282              ‐0.169            0.242       0.408                 0.352
  q14                         Difficulty in focusing attention   **0.767**      0.230          −0.332                0.275              −0.188            0.234       0.426                 0.354
  q24                         Fatigue                            **0.752**      0.195          −0.432                0.262              −0.461            0.296       0.241                 0.277
  q55                         Stress                             **0.721**      0.199          −0.373                0.203              −0.377            0.232       0.248                 0.260
  q25                         Foggy thinking                     **0.702**      0.184          −0.503                0.375              −0.323            0.244       0.292                 0.338
  q21                         Exhaustion                         **0.669**      0.161          −0.468                0.231              −0.426            0.314       0.234                 0.266
  q2                          Anxiety                            **0.633**      0.194          −0.184                0.165              −0.229            0.381       0.099                 0.320
  q34                         Memory difficulties                **0.472**      0.120          −0.206                0.197              −0.440            0.214       0.448                 0.300
  q54                         Sleep disturbances                 **0.439**      0.212          −0.334                0.298              −0.344            0.117       0.348                 0.313
  q49                         Skin irritation                    0.232          **0.757**      −0.212                0.270              −0.248            0.307       0.166                 0.168
  q52                         Skin redness                       0.235          **0.741**      −0.236                0.187              −0.071            0.342       0.165                 0.228
  q53                         Skin swelling                      0.137          **0.720**      −0.186                0.149              −0.121            0.225       0.221                 0.269
  q56                         Tingling sensations                0.193          **0.689**      −0.203                0.284              −0.270            0.105       0.290                 0.192
  q41                         Pain/Soreness of the skin          0.126          **0.611**      −0.183                0.360              −0.272            0.250       0.219                 0.217
  q48                         Skin burning sensations            0.073          **0.548**      −0.164                0.240              −0.270            −0.056      0.273                 0.231
  q51                         Skin rash                          0.319          **0.427**      −0.306                0.238              0.051             0.255       0.242                 0.190
  q6                          Blisters on the skin               0.129          **0.397**      −0.141                0.247              −0.019            0.388       −0.012                0.264
  q26                         Headaches                          0.349          0.162          **−0.881**            0.277              −0.224            0.206       0.196                 0.266
  q20                         Dull headaches                     0.294          0.195          **−0.871**            0.282              −0.293            0.260       0.232                 0.305
  q35                         Migraines                          0.198          0.115          **−0.851**            0.187              −0.157            0.125       0.217                 0.193
  q28                         Heaviness in the head              0.436          0.195          **−0.803**            0.301              −0.339            0.196       0.208                 0.356
  q46                         Sharp pain in the head             0.209          0.290          **−0.790**            0.314              −0.254            0.183       0.263                 0.303
  q22                         Eye problems                       0.365          0.227          **−0.442**            0.364              −0.348            0.307       0.222                 0.189
  q15                         Digestive problems                 0.351          0.217          **−0.406**            0.374              −0.087            0.277       0.394                 0.327
  q43                         Pressure in the ear                0.198          0.272          −0.323                **0.716**          −0.251            0.122       0.308                 0.305
  q39                         Pain in the ear                    0.174          0.190          −0.324                **0.713**          −0.153            0.181       0.356                 0.320
  q44                         Ringing in the ear                 0.266          0.181          −.0284                **0.648**          −0.230            0.217       0.163                 0.340
  q38                         Nausea                             0.331          0.196          −0.420                **0.561**          −0.182            0.327       0.355                 0.382
  q23                         Facial prickling                   0.146          0.401          −0.291                **0.559**          −0.141            0.130       0.378                 0.229
  q57                         Warmth in the ear                  0.143          0.365          −0.094                **0.533**          −0.221            −0.079      0.177                 0.278
  q33                         Loss of appetite                   0.390          0.078          −0.365                **0.437**          −0.065            0.209       0.414                 0.267
  q42                         Pain/Warmth in the head            0.264          0.259          −0.257                **0.436**          −0.275            0.225       0.205                 0.370
  q36                         Muscle tension                     0.235          0.212          −0.291                0.278              **−0.661**        0.178       0.330                 0.168
  q37                         Muscle weakness                    0.270          0.190          −0.225                0.477              **−0.591**        0.153       0.335                 0.268
  q40                         Pain in joints                     0.210          0.192          −0.341                0.461              **−0.587**        0.327       0.293                 0.233
  q50                         Numbness                           0.255          0.339          −0.238                0.421              **−0.568**        0.125       0.253                 0.285
  q47                         Sickness                           0.401          0.330          −0.359                0.332              **−0.558**        0.236       0.268                 0.373
  q4                          Back pain                          0.344          0.208          −0.332                0.198              **−0.550**        0.338       0.095                 0.356
  q7                          Blurry vision                      0.351          0.090          −0.311                0.229              **−0.460**        0.295       0.211                 0.358
  q29                         High blood pressure                0.097          0.099          −0.151                −0.041             **−0.387**        0.052       0.235                 0.310
  q1                          Allergies                          0.226          0.265          −0.173                0.155              −0.056            **0.707**   0.105                 0.075
  q45                         Runny or stuffy nose               0.264          0.208          −0.248                0.278              −0.142            **0.612**   0.333                 0.073
  q19                         Dry skin                           0.313          0.455          −0.305                0.211              −0.167            **0.546**   0.142                 0.177
  q3                          Asthma                             0.054          0.063          −0.037                −0.046             −0.130            **0.525**   0.106                 0.197
  q18                         Dry cough                          0.164          0.089          −0.231                0.199              −0.252            **0.497**   0.320                 0.320
  q5                          Bad taste in the mouth             0.305          0.208          −0.287                0.208              −0.346            **0.418**   0.388                 0.397
  q31                         Impaired sense of smell            0.105          0.153          −0.134                0.179              −0.132            0.193       **0.789**             0.173
  q32                         Impaired sense of taste            0.135          0.195          −0.193                0.203              −0.241            0.135       **0.770**             0.184
  q30                         Hoarse dry throat                  0.333          0.177          −0.244                0.314              −0.339            0.394       **0.462**             0.309
  q16                         Disorientation                     0.223          0.127          −0.080                0.013              −0.086            −0.024      **0.450**             0.431
  q9                          Cardiac(Heart) pains               0.178          0.161          −0.268                0.268              −0.168            0.124       0.231                 **0.824**
  q10                         Chest pains                        0.254          0.228          −0.318                0.312              −0.279            0.226       0.298                 **0.782**
  q8                          Breathing difficulties             0.318          0.214          −0.260                0.360              −0.383            0.374       0.292                 **0.644**
  q27                         Heart palpitations                 0.232          0.225          −0.358                0.367              −0.448            0.225       0.240                 **0.620**
  q17                         Dizziness                          0.353          0.151          −0.450                0.451              −0.180            0.273       0.086                 **0.490**
  q11                         Cold sweat                         0.385          0.265          −0.194                0.299              −0.056            0.229       0.268                 **0.473**

Fifty‐seven symptoms in control group (*n* = 1,306) were analyzed by forced eight‐factor principal component analysis with oblimin rotation and Kaiser\'s normalization as described by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\].
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###### 

Factor Loadings for Controls, EHS Group[^a^](#bem21987-note-0011){ref-type="fn"} and Self‐Selected EHS Subjects in a Forced Eight‐Factor Principal Component Analysis

                        Group                                                
  --------------------- ---------------------------------- -------- -------- --------
  Nervous                                                                    
  q12                   Depression                         0.811    0.792    0.736
  q13                   Difficulty in concentrating        0.806    0.656    0.790
  q14                   Difficulty in focusing attention   0.767    0.639    0.755
  q24                   Fatigue                            0.752    0.786    0.584
  q55                   Stress                             0.721    0.776    0.651
  q25                   Foggy thinking                     0.702    0.560    0.770
  q21                   Exhaustion                         0.669    0.677    0.521
  q2                    Anxiety                            0.633    0.678    0.699
  q34                   Memory difficulties                0.472    0.489    −0.607
  q54                   Sleep disturbances                 0.439    0.486    0.657
  Skin‐related                                                               
  q49                   Skin irritation                    0.757    0.742    0.678
  q52                   Skin redness                       0.741    0.695    0.631
  q53                   Skin swelling                      0.720    0.722    0.705
  q56                   Tingling sensations                0.689    0.698    0.772
  q41                   Pain/soreness of the skin          0.611    0.603    0.700
  q48                   Skin burning sensations            0.548    0.744    −0.533
  q51                   Skin rash                          0.427    0.462    0.457
  q6                    Blisters on the skin               0.397    0.516    0.350
  Head‐related                                                               
  q26                   Headache                           −0.881   −0.831   0.827
  q20                   Dull headache                      −0.871   −0.779   0.794
  q35                   Migraines                          −0.851   −0.807   0.751
  q28                   Heaviness in the head              −0.803   −0.672   0.803
  q46                   Sharp pain in the head             −0.790   −0.728   0.689
  q22                   Eye problems                       −0.442   0.509    0.554
  q15                   Digestive problems                 −0.406   −0.551   0.603
  Auditory vestibular                                                        
  q43                   Pressure in the ear                0.716    0.795    −0.724
  q39                   Pain in the ear                    0.713    0.738    −0.707
  q44                   Ringing in the ear                 0.648    0.583    −0.497
  q38                   Nausea                             0.561    0.591    0.574
  q23                   Facial prickling                   0.559    0.570    0.672
  q57                   Warmth in the ear                  0.533    0.625    0.455
  q33                   Loss of appetite                   0.437    −0.432   0.720
  q42                   Pain/warmth in the head            0.436    0.507    0.531
  Musculo/Skeletal                                                           
  q36                   Muscle tension                     −0.661   0.598    0.748
  q37                   Muscle weakness                    −0.591   0.671    0.661
  q40                   Pain in the joints                 −0.587   0.625    0.688
  q50                   Numbness                           −0.568   0.529    −0.650
  q47                   Sick feeling                       −0.558   0.497    0.572
  q4                    Back pain                          −0.550   0.458    0.666
  q7                    Blurry vision                      −0.460   0.577    −0.624
  q29                   High blood pressure                −0.387   0.329    0.751
  Allergy‐related                                                            
  q1                    Allergies                          0.707    0.694    0.498
  q45                   Runny or stuffy nose               0.612    0.544    0.543
  q19                   Dry skin                           0.546    0.689    0.568
  q3                    Asthma                             0.525    0.531    0.714
  q18                   Dry cough                          0.497    0.485    0.655
  q5                    Bad taste in the mouth             0.418    0.502    0.568
  Sensory                                                                    
  q31                   Impaired sense of smell            0.789    0.760    0.675
  q32                   Impaired sense of taste            0.770    0.734    0.461
  q30                   Hoarse dry throat                  0.462    0.516    0.581
  q16                   Disorientation                     0.450    0.493    −0.753
  Heart/Chest‐related                                                        
  q9                    Cardiac/heart pains                0.824    0.812    0.684
  q10                   Chest pains                        0.782    0.816    0.654
  q8                    Breathing difficulties             0.644    0.516    0.700
  q27                   Heart palpitations                 0.620    0.568    0.542
  q17                   Dizziness                          0.490    0.553    0.589
  q11                   Cold sweat                         0.473    0.445    0.510

EHS group Controls who had a score higher than 1 point for q67 ("Are you sensitive to electromagnetic fields, e.g., radio frequencies and magnetic fields produced by electrical objects such as televisions, computers, and mobile phones?").

© 2016 Wiley Periodicals, Inc.

Reliability {#bem21987-sec-0026}
-----------

The test--retest method revealed significant correlations for ICCs of all 5‐point scale questions and total scores of each subscale (Table [4](#bem21987-tbl-0004){ref-type="table-wrap"}). A high to moderate value of over 0.6 (0.623*--*0.863) was noted with the exception of component 4, q64, q65, and q71 (Table [4](#bem21987-tbl-0004){ref-type="table-wrap"}). In addition, *κ* coefficients of q68 and q69 were 0.442 and 0.484, respectively. Although significant, reproducibility of these values was not high. Taken together, these findings indicate high reliability of the Japanese EHS questionnaire. High Cronbach\'s a coefficients (0.853--0.953) from all subscales, with the exception of "Reaction to EMFs (0.528)," indicated good internal consistency for each question (Table [5](#bem21987-tbl-0005){ref-type="table-wrap"}).

###### 

Intraclass Correlation Coefficients of Test--Retest Data

  Subscales                                                                            Questionnaire items                    Intraclass correlation coefficient (ICC)   *P*‐value
  ------------------------------------------------------------------------------------ -------------------------------------- ------------------------------------------ -----------
  II‐1 Symptoms                                                                        Component 1_Nervous score (10 items)   0.791                                      \<0.0001
  Component 2_Skin‐related score (8 items)                                             0.863                                  \<0.0001                                   
  Component 3_Head‐related score (7 items)                                             0.705                                  \<0.0001                                   
  Component 4\_ Auditory vestibular score (8 items)                                    0.585                                  \<0.0001                                   
  Component 5_Musculoskeletal score (8 items)                                          0.716                                  \<0.0001                                   
  Component 6_Allergy‐related score (6 items)                                          0.815                                  \<0.0001                                   
  Component 7_Sensory score (4 items)                                                  0.641                                  \<0.0001                                   
  Component 8\_ Heart/chest‐related score (6 items)                                    0.708                                  \<0.0001                                   
  Total score of Symptoms (57 items)                                                   0.773                                  \<0.0001                                   
  II‐2 EMF‐producing objects                                                           q58_Computers                          0.573                                      \<0.0001
  q59_Electric appliances                                                              0.623                                  \<0.0001                                   
  q60_Fluorescent lighting                                                             0.789                                  \<0.0001                                   
  q61_Microwave ovens                                                                  0.816                                  \<0.0001                                   
  q62_Mobile phones                                                                    0.645                                  \<0.0001                                   
  q63_Power lines                                                                      0.658                                  \<0.0001                                   
  q64_Radio/Television transmitters                                                    0.389                                  0.0012                                     
  q65_Telecommunication masts                                                          0.421                                  0.0003                                     
  q66_Televisions                                                                      0.620                                  \<0.0001                                   
  Total score of EMF‐producing objects (9 items)                                       0.709                                  \<0.0001                                   
  II‐3 Reaction to EMFs                                                                q67_Sensitive to EMFs                  0.656                                      \<0.0001
  q70\_ Occurrences of static electric shock                                           0.719                                  *\<*0.0001                                 
  q71_Negative health change around EMFs                                               0.417                                  0.0003                                     
  Total score of Reaction to EMFs (5 items)[^a^](#bem21987-note-0014){ref-type="fn"}   0.655                                  \<0.0001                                   
  III General health                                                                   1\_ Well‐being                         0.829                                      \<0.0001
  2\_ Good health                                                                      0.670                                  \<0.0001                                   
  3_1 Sleep                                                                            0.703                                  \<0.0001                                   
  3_2 Sleeping hours per day                                                           0.746                                  \<0.0001                                   
  3_3 Sleep disorder                                                                   0.715                                  \<0.0001                                   
  IV‐1 THI‐D                                                                           Total score of THI‐D (10 items)        0.783                                      \<0.0001

Test--retest reliability was estimated by calculating intraclass correlation coefficients (ICC); significance of ICC was determined using an *F*‐test. A total of 173 people from the general population participated in this study (see text).

EMF, electromagnetic field; THI‐D, todai health index‐depression scale.

Total score of reaction to EMF score: calculated by adding scores of q67--q71.
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###### 

Cronbach\'s *α* Coefficient from Each Subclass in Controls and Self‐Selected EHS Subjects

                                                Cronbach\'s alpha coefficient   
  --------------------------------------------- ------------------------------- -------
  II‐1 Symptoms (57 items)                      0.953                           0.968
  Eight factor principal components (8 items)   0.872                           0.921
  Component 1 (Nervous; 10 items)               0.905                           0.928
  Component 2 (Skin‐related; 8 items)           0.794                           0.865
  Component 3 (Head‐related; 7 items)           0.873                           0.904
  Component 4 (Auditory vestibular; 8 items)    0.780                           0.832
  Component 5 (Musculo‐skeletal; 8 items)       0.785                           0.837
  Component 6 (Allergy‐related; 6 items)        0.678                           0.657
  Component 7 (Sensory; 4 items)                0.574                           0.616
  Component 8 (Heart/chest‐related; 6 items)    0.797                           0.837
  II‐2 EMF‐producing objects (9 items)          0.900                           0.953
  II‐3 Reaction to EMFs (5 items)               0.500                           0.582
  IV‐1 THI‐D (10 items)                         0.893                           0.912

EMF, electromagnetic field; THI‐D, todai health index‐depression scale.
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Total Symptom Score and Eight Symptoms Component {#bem21987-sec-0027}
------------------------------------------------

Total symptom scores for self‐selected EHS subjects were widely distributed, as seen in Figure [1](#bem21987-fig-0001){ref-type="fig"}a. The 25th, 50th, and 75th percentiles for total symptom scores in controls were 16, 29, and 47 points, respectively. The median score of self‐selected EHS subjects was significantly higher than that of controls (*P* \< 0.0005), as shown in Figure [1](#bem21987-fig-0001){ref-type="fig"}b. An outlier is defined as a point that exceeds 1.5 times the interquartile range from the 75th percentile line, and it should be noted that there were 48 (3.7%) outliers for the controls. With regard to the median score of eight principal components, shapes of the radar chart in both groups were quite similar (Fig. [1](#bem21987-fig-0001){ref-type="fig"}c). The median score of each component for self‐selected EHS subjects was significantly higher (*P* \< 0.0005) than that of controls.

Validity {#bem21987-sec-0028}
--------

Firstly, validity was evaluated in the same way as reported by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\], that is, by comparing EHS responses of self‐selected EHS subjects with those of the control group; the Mann--Whitney *U*‐test with Bonferroni correction for multiple tests (100 tests; *P* \< 0.0005) was used, revealing significant differences between both groups (Table [6](#bem21987-tbl-0006){ref-type="table-wrap"}). Furthermore, the *χ* ^2^ test revealed that a significantly higher (*P* \< 0.0005) proportion of self‐selected EHS subjects (87.4%) had identified EMF‐producing object(s) and described, in detail, specific symptoms they believed were caused by the object(s) (q68, *χ* ^2^ = 150.20, *P* \< 0.0005) when compared with controls (12.6%). A significantly higher number of self‐selected EHS subjects (66.4%) experienced severe electric shock (q69, *χ* ^2^ = 10.0, *P* = 0.003) when compared with controls (49.6%). In summary, Mann--Whitney *U*‐ and *χ* ^2^ tests revealed that when compared with age‐ and sex‐matched controls, self‐selected EHS subjects described a greater severity of symptoms, poorer levels of general health and well‐being, and the belief that their symptoms were caused by exposure to objects that emitted EMFs.

###### 

Answer Distribution for Reactions to Nine EMF‐Producing Objects in Self‐Selected EHS Subjects and in Age‐ and Sex‐Matched Controls

  Objects                                                                              Not at all *n* (%)   A little bit *n* (%)   Moderately *n* (%)   Quite a bit *n* (%)   A great deal *n* (%)   *Z* [^a^](#bem21987-note-0018){ref-type="fn"} *P*‐value
  ------------------------------------------------------------------------------------ -------------------- ---------------------- -------------------- --------------------- ---------------------- -------------------------------------------------------------
  q58_Computers                                                                                                                                                                                      
  Controls                                                                             82 (65.1)            24 (19.0)              13 (10.3)            3 (2.4)               4 (3.2)                −9.23
  Self‐selected EHS subjects                                                           16 (14.4)            14 (12.6)              27 (24.3)            18 (16.2)             36 (32.4)              2.72 × 10^−20^ [\*](#bem21987-note-0021){ref-type="fn"}
  q59_Electrical appliances                                                                                                                                                                          
  Controls                                                                             98 (79.7)            16 (13.0)              5 (4.1)              3 (2.4)               1 (0.8)                −10.724
  Self‐selected EHS subjects                                                           13 (12.4)            19 (18.1)              20 (19.1)            18 (17.1)             35 (33.3)              7.85 × 10^−27^ [\*](#bem21987-note-0021){ref-type="fn"}
  q60_Fluorescent lighting                                                                                                                                                                           
  Controls                                                                             110 (88.7)           8 (6.5)                3 (2.4)              2 (1.6)               1 (0.8)                −9.772
  Self‐selected EHS subjects                                                           33 (28.5)            14 (12.1)              15 (12.9)            21 (18.1)             33 (28.4)              1.49 × 10^−22^ [\*](#bem21987-note-0021){ref-type="fn"}
  q61_Microwave ovens                                                                                                                                                                                
  Controls                                                                             108 (86.4)           9 (7.2)                4 (3.2)              2 (1.6)               2 (1.6)                −9.005
  Self‐selected EHS subjects                                                           31 (31.0)            9 (9.0)                8 (8.0)              16 (16.0)             36 (36.0)              2.16 ×** **10^−19^ [\*](#bem21987-note-0021){ref-type="fn"}
  q62_Mobile phones                                                                                                                                                                                  
  Controls                                                                             95 (75.4)            14 (11.1)              9 (7.1)              5 (4.0)               3 (2.4)                −10.38
  Self‐selected EHS subjects                                                           16 (14.3)            12 (10.7)              14 (12.5)            16 (14.3)             54 (48.2)              3.06 × 10^−25^ [\*](#bem21987-note-0021){ref-type="fn"}
  q63_Power lines                                                                                                                                                                                    
  Controls                                                                             105 (85.4)           7 (5.7)                7 (5.7)              1 (0.8)               3 (2.4)                −8.499
  Self‐selected EHS subjects                                                           31 (32.0)            10 (10.3)              9 (9.3)              14 (14.4)             33 (34.0)              1.92 × 10^−17^ [\*](#bem21987-note-0021){ref-type="fn"}
  q64_Radio/Television transmitters                                                                                                                                                                  
  Controls                                                                             108 (87.8)           8 (6.5)                5 (4.1)              1 (0.8)               1 (0.8)                −8.045
  Self‐selected EHS subjects                                                           31 (37.8)            6 (7.3)                9 (11.0)             9 (11.0)              27 (32.9)              8.64 × 10^−16^ [\*](#bem21987-note-0021){ref-type="fn"}
  q65_Telecommunication masts                                                                                                                                                                        
  Controls                                                                             108 (87.8)           4 (3.3)                8 (6.5)              2 (1.6)               1 (0.8)                −11.288
  Self‐selected EHS subjects                                                           15 (14.7)            10 (9.8)               12 (11.8)            12 (11.8)             53 (52.0)              1.51 × 10^−29^ [\*](#bem21987-note-0021){ref-type="fn"}
  q66_Televisions                                                                                                                                                                                    
  Controls                                                                             95 (74.8)            20 (15.7)              8 (6.3)              3 (2.4)               1 (0.8)                −8.493
  Self‐selected EHS subjects                                                           27 (23.9)            27 (23.9)              20 (17.7)            16 (14.2)             23 (20.4)              2.02 × 10^−17^ [\*](#bem21987-note-0021){ref-type="fn"}
  Total score of EMF‐producing objects                                                 0                    1--9                   10--18               19--27                28--36                 *Z P*‐value
  Controls                                                                             72 (56.7)            42 (33.1)              9 (7.1)              3 (2.4)               1 (0.8)                −10.783
  Self‐selected EHS subjects                                                           8 (6.3)              29 (22.8)              27 (21.3)            39 (30.7)             24 (18.9)              4.16 × 10^−27^ [\*](#bem21987-note-0021){ref-type="fn"}
  q67[^b^](#bem21987-note-0019){ref-type="fn"}\_Sensitive to EMFs                                                                                                                                    
  Controls                                                                             106 (86.2)           14 (11.4)              3 (2.4)              0 (0.0)               0 (0.0)                −12.58
  Self‐selected EHS subjects                                                           11 (9.0)             19 (15.6)              17 (13.9)            14 (11.5)             61 (50.0)              2.71 × 10^−36^ [\*](#bem21987-note-0021){ref-type="fn"}
  q70[^c^](#bem21987-note-0020){ref-type="fn"}\_Occurrences of static electric shock                                                                                                                 
  Controls                                                                             32 (25.2)            51 (40.2)              17 (13.4)            16 (12.6)             11 (8.7)               −3.445
  Self‐selected EHS subjects                                                           12 (9.7)             48 (38.7)              24 (19.4)            17 (13.7)             23 (18.5)              5.71 × 10^−4^ n.s.

Note: Differences in scores between groups were analyzed using a Mann--Whitney *U*‐test with Bonferroni correction for multiple tests (100 tests; *P* \< 0.0005).

EMF electromagnetic field; n.s: not significant.

*Z*: Mann--Whitney *U*‐test; *α* level: 0.0005.

q67: "Are you sensitive to electromagnetic fields (e.g., radio frequency and magnetic fields produced by electrical objects such as television, computers, and mobile phones)?"

q70: "How frequently do you experience static shocks (e.g., from metals and car doors)?"

*P* ≤ 0.00005.
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Furthermore, in the present study, logistic regression analysis was also performed to compare the discriminatory power of each question in the Japanese EHS questionnaire (Table [7](#bem21987-tbl-0007){ref-type="table-wrap"}). Results of the logistic regression analysis revealed that the odds ratio (OR; 0.85) for mean working hours per day was significantly lower in self‐selected EHS subjects than in controls (I. Biographical Information). Furthermore, ORs for total symptoms score and for each of the eight principal components (components 1--8; 1.05*--*1.60) were significantly higher (II--1. Symptoms). Similarly, ORs for total score (1.22) and for each of the nine EMF‐producing objects (2.61--4.29), especially electrical appliances (q59, 4.29), telecommunication masts (q65, 3.87), and fluorescent lighting (q60, 3.60), were also very high (II--2. EMF‐producing Objects). The ORs for all questions, particularly q68 (90.96) and q67 (9.96), were very high (II--3. Reactions to EMFs), whereas ORs for well‐being (0.59), good health (0.34), and sleep (0.53) were significantly lower (III. General Health). The OR for average sleeping hours per day was 1.22, indicating that self‐selected EHS subjects slept longer than controls. However, the OR for sleep disorders was 2.22, implying that self‐selected EHS subjects experienced more sleep disorders than controls. Furthermore, the OR for the total score of THI‐D was 1.21, suggestive of an increased tendency for depression amongst self‐selected EHS subjects when compared with controls.

###### 

Estimates of the Relative Risks of EHS for Each Potential Predictor Tested Separately in the Japanese EHS Questionnaire

                                                                        Questionnaire items                          Odds ratio     95%CI (min--max)   *P‐*value
  --------------------------------------------------------------------- -------------------------------------------- -------------- ------------------ ----------------
  I Biographical                                                        Final academic background                    1.63           (1.08--2.46)       0.021
  Mean working hours per day[^a^](#bem21987-note-0024){ref-type="fn"}   0.85                                         (0.79--0.93)   1.27 × 10^−4^      
  II‐1 Symptoms                                                         Component 1_Nervous score (10 items)         1.15           (1.11--1.19)       2.83 × 10^−12^
  Component 2_Skin‐related score (8 items)                              1.26                                         (1.17--1.35)   4.37 × 10^−10^     
  Component 3_Head‐related score (7 items)                              1.18                                         (1.12--1.24)   7.25 × 10^−11^     
  Component 4_Auditory vestibular score (8 items)                       1.44                                         (1.30--1.59)   1.87 × 10^−12^     
  Component 5_Musculoskeletal score (8 items)                           1.21                                         (1.14--1.28)   3.85 × 10^−11^     
  Component 6_Allergy‐related score (6 items)                           1.28                                         (1.19--1.38)   4.12 × 10^−10^     
  Component 7_Sensory score (4 items)                                   1.60                                         (1.35--1.90)   6.33 × 10^−8^      
  Component 8\_ Heart/chest‐related score (6 items)                     1.47                                         (1.33--1.64)   8.78 × 10^−13^     
  Total score of Symptoms (57 items)                                    1.05                                         (1.03--1.06)   6.78 × 10^−14^     
  II‐2 EMF^c^‐producing objects                                         q58_Computers                                2.85           (2.20--3.71)       4.77 × 10^−15^
  q59_Electrical appliances                                             4.29                                         (2.97--6.19)   8.33 × 10^−15^     
  q60_Fluorescent lighting                                              3.60                                         (2.52--5.14)   2.03 × 10^−12^     
  q61_Microwave ovens                                                   2.87                                         (2.15--3.83)   9.45 × 10^−13^     
  q62_Mobile phones                                                     2.98                                         (2.32--3.83)   1.48 × 10^−17^     
  q63_Power lines                                                       2.61                                         (1.99--3.42)   3.74 × 10^−12^     
  q64_Radio/Television transmitters                                     2.92                                         (2.10--4.05)   1.75 × 10^−10^     
  q65_Telecommunication masts                                           3.87                                         (2.79--5.38)   5.94 × 10^−16^     
  q66_Televisions                                                       2.95                                         (2.17--4.00)   4.94 × 10^−12^     
  Total score of EMF‐producing objects (9 items)                        1.22                                         (1.16--1.28)   6.90 × 10^−15^     
  II‐3 Reactions to EMFs                                                q67_Sensitive to EMFs                        9.66           (5.16--18.09)      1.40 × 10^−12^
                                                                        q68_Detailed description                     90.96          (38.61--214.26)    5.85 × 10^−25^
                                                                        q69_Experience a severe electric shock       2.40           (1.44--4.01)       8.19 × 10^−4^
                                                                        q70_Occurrences of static electric shock     1.40           (1.14--1.71)       0.001
                                                                        Total score of Reactions to EMFs (4 items)   2.20           (1.80--2.68)       7.56 × 10^−15^
  III General health                                                    1\_ Well‐being                               0.59           (0.45--0.78)       2.05 × 10^−4^
  2\_ Good health                                                       0.34                                         (0.24--0.48)   3.74 × 10^−10^     
  3_1 Sleep                                                             0.53                                         (0.40--0.70)   9.44 × 10^−6^      
  3_2 Sleeping hours per a day                                          1.22                                         (0.99--1.50)   0.058              
  3_3 Sleep disorder                                                    2.22                                         (1.73--2.84)   3.37 × 10^−10^     
  4\_ Chronic illnesses                                                 1.83                                         (1.10--3.02)   0.019              
  IV‐1 THI‐D                                                            Total score of THI‐D (10 items)              1.21           (1.14--1.28)       2.20 × 10^−11^

Note: Differences in scores between groups were analyzed using bivariate logistic regression analysis with Bonferroni correction for multiple tests (100 tests; *P* \< 0.0005).

CI, confidence interval; EMF, electromagnetic field; THI‐D, todai health index‐depression scale.

Mean working hours per day: including housework and school hours.

© 2016 Wiley Periodicals, Inc.

Multiple Logistic Regression and ROC Analyses {#bem21987-sec-0029}
---------------------------------------------

Multiple logistic regression and ROC analyses were performed in self‐selected EHS subjects, and in sex‐ and age‐matched control groups to narrow down items that can aid in discrimination of EHS individuals from the general population during screening. Multiple logistic regression analysis revealed the following three items: "Total symptom score;" "q67, Sensitive to EMFs;" and "q68, Detailed description" (Table [8](#bem21987-tbl-0008){ref-type="table-wrap"}). The area under the ROC curve for predicted values was high (0.976). Sensitivity and specificity of predicted values using the three items were 94.3% and 94.3%, respectively, higher than analysis results obtained from individual items (Table [9](#bem21987-tbl-0009){ref-type="table-wrap"}). Based on these findings, we suggested the following preliminary screening criteria for EHS individuals from the general population: (1) the total symptom score should be greater than or equal to 47 points (the 75th percentile of the controls, Fig. [1](#bem21987-fig-0001){ref-type="fig"}a); (2) the score for q67 ("Are you sensitive to electromagnetic fields?") should be greater than or equal to 1; and (3) individuals should be able to describe, in detail, the EMF source and the kind of symptoms developed in response to q68. A total of 82 (64.6%) self‐selected EHS subjects and 60 (4.59%) controls met the set screening criteria for EHS. Significant differences in resident areas, final academic background, and occupation were not noted between individual characteristics of these 60 controls and those of the remaining 1,246 control subjects (Table [1](#bem21987-tbl-0001){ref-type="table-wrap"}). However, the number of females was significantly higher among the 60 controls who met the set screening criteria (*P* \< 0.0005) when compared to others (Table [1](#bem21987-tbl-0001){ref-type="table-wrap"}).

###### 

Discrimination Power of EHS Scales When Used Alone (Univariate) or When Combined in a Multiple Logistic Regression Model

  Scale                                                      *P‐*value        Odds ratios (95%CI) for one point increase   Area under ROC curve
  ---------------------------------------------------------- ---------------- -------------------------------------------- ----------------------
  Individual scale                                                                                                         
  Total symptom score                                        1.77 × 10^−4^    1.044 (1.021--1.067)                         0.851 (0.803--0.900)
  q67_Sensitive to EMFs                                      3.73 × 10^−4^    3.119 (1.667--5.835)                         0.934 (0.901--0.968)
  q68_Detailed description                                   7.18 × 10^−6^    21.252 (5.594--80.737)                       0.906 (0.864--0.948)
  Multiple scales[^a^](#bem21987-note-0027){ref-type="fn"}                                                                 
  Total symptom score                                        1.17  × 10^−4^   1.041 (1.020--1.063)                         
  q67_Sensitive to EMFs^d^                                   1.41 × 10^−5^    3.503 (1.989--6.169)                         0.976 (0.959--0.994)
  q68_Detailed description                                   2.64 × 10^−7^    22.755 (6.924--74.784)                       

Note: Significant differences in scores between groups were evaluated by setting an *α* value of 0.0005 in consideration of multiplicity, according to a Bonferroni correction.

CI, confidence interval; ROC, receiver operating characteristic; EMFs, electromagnetic fields.

Multiple scales: each of three items listed below is a factor in one multiple logistic prediction (see text).

© 2016 Wiley Periodicals, Inc.

###### 

Sensitivity and Specificity Resulting From the Application of High Cut‐Off Points for Total Symptoms, q67 and q68 scales, and for All Three Scales Taken Together

  Scale                                                            Sensitivity (%)   Specificity (%)
  ---------------------------------------------------------------- ----------------- -----------------
  Individual scale                                                                   
  Total symptom cut‐off                                                              
  45                                                               73.8              79.7
  **47** [^a^](#bem21987-note-0029){ref-type="fn"}                 **73.8**          **81.3**
  48                                                               72.1              81.3
  q67_Sensitive to EMFs cut‐off                                                      
  **1**                                                            **91.0**          **86.2**
  2                                                                75.4              97.6
  3                                                                61.5              100.0
  q68_Detailed description cut‐off                                                   
  **1**                                                            **88.5**          **92.7**
  Multiple scale scores[^b^](#bem21987-note-0030){ref-type="fn"}                     
  Total symptom score                                                                
  q67_Sensitive to EMFs                                            **94.3**          **94.3**
  q68_Detailed description                                                           

Note: Significant differences in scores between groups were evaluated by setting an *α* value of 0.0005 in consideration of multiplicity according to a Bonferroni correction.

47: The 75th percentile of controls.

Multiple scale scores: Each of three items listed is a factor in one multiple logistic prediction (see text).

© 2016 Wiley Periodicals, Inc.

EMF Objects That Self‐Selected EHS Subjects Believed Were the Cause of Their Symptoms {#bem21987-sec-0030}
-------------------------------------------------------------------------------------

Almost none of the controls responded to q68 ("Provide a detailed description of EMF‐producing objects and the specific symptoms caused by these."), whereas 111 (87.4%) of the 127 self‐selected EHS subjects responded to the same question in detail. Thus, we analyzed contents described by the 111 subjects in response to q68.

A summary of nine EMF‐producing objects (q58--66), which Japanese self‐selected EHS subjects believed were the cause of their symptoms, is presented in Figure [2](#bem21987-fig-0002){ref-type="fig"}a. Furthermore, details of electrical appliances listed in this study are presented in Figure [2](#bem21987-fig-0002){ref-type="fig"}b.

![EMF sources. **2a**. Electromagnetic field objects that Japanese self‐selected EHS subjects (*n* = 165) believed as cause of symptoms (multiple answers). **2b**. Details of electrical appliances from Fig. [2](#bem21987-fig-0002){ref-type="fig"}a. Outdoor units^a^ included air conditioner compressors and heat pump‐type water heater systems, among others (multiple answers).](BEM-37-353-g002){#bem21987-fig-0002}

The following three additional types of EMF‐producing objects, other than the nine (q58‐q66) included in the questionnaire, were also reported to cause symptoms in Japanese self‐selected EHS subjects: vehicles (75 respondents, 63.6%) including cars and buses (28.8%), trains (21.2%), Shinkansen high speed bullet trains (3.4%), and subways (3.4%); telecommunications equipment other than mobile phones (61 respondents, 53.4%) including wireless LANs (22.9%), landline phones (15.3%), security sensors (12.7%), and equipment using Wi‐Fi (7.6%); and medical equipment (nine respondents, 7.6%) including magnetic resonance imaging (MRI; 2.5%), medical measuring instruments emitting low‐frequency EMFs (1.7%), X‐ray (0.8%), dental equipment (0.8%), and apparatus measuring bone density (0.8%).

Physician‐Diagnosed Chronic Illness (Past and Present) {#bem21987-sec-0031}
------------------------------------------------------

Results from 116 of the 127 self‐selected EHS subjects and 681 of the 1,306 subjects among the controls, who agreed to provide valid responses for a list of "physician‐diagnosed chronic illnesses," are shown in Table [10](#bem21987-tbl-0010){ref-type="table-wrap"}. At the time of answering, none of the controls were undergoing treatment for environmental hypersensitivity (SHS, MSC, and EHS) as depicted in Table [10](#bem21987-tbl-0010){ref-type="table-wrap"}. However, in 46 (39.66%) of the 116 self‐selected EHS subjects, their symptoms had been diagnosed as EHS, which was further complicated by MCS. A *χ* ^2^ test revealed that proportions of participants who claimed to be undergoing treatment for chronic illnesses entitled "Autonomic imbalance" and "Other allergy symptoms" at the time of the survey were highly significant among the self‐selected EHS subjects compared with controls (Table [10](#bem21987-tbl-0010){ref-type="table-wrap"}).

###### 

Comparison of the Prevalence of Chronic Illnesses Between Controls and Self‐Selected EHS Subjects

                                                                   Chronic illnesses at present   Chronic illnesses in the past                                                                                                               
  ---------------------------------------------------------------- ------------------------------ ------------------------------- ---------------- ---------------------------------------------- ------------- ------------ ---------------- ----------------------------------------------
  Diabetes mellitus                                                7 (1.03)                       1 (0.86)                        0.868            n.s.                                           11 (1.62)     2 (1.72)     0.932            n.s.
  High blood pressure                                              49 (7.20)                      5 (4.31)                        0.253            n.s.                                           37 (5.43)     7 (6.03)     0.793            n.s.
  Heart diseases                                                   10 (1.47)                      2 (1.72)                        0.834            n.s.                                           9 (1.32)      6 (5.17)     0.005            n.s.
  Autonomic imbalance                                              5 (0.73)                       6 (5.17)                        1.52 × 10^−4^    [\*\*](#bem21987-note-0035){ref-type="fn"}     23 (3.38)     20 (17.24)   1.00 × 10^−9^    [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Migraines                                                        8 (1.17)                       2 (1.72)                        0.623            n.s.                                           33 (4.85)     9 (7.76)     0.194            n.s.
  Allergy symptoms[^a^](#bem21987-note-0032){ref-type="fn"}        84 (12.33)                     16 (13.79)                      0.661            n.s.                                           285 (41.85)   75 (64.66)   5.06 × 10^−6^    [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Atopic dermatitis                                                11 (1.62)                      3 (2.59)                        0.462            n.s.                                           60 (8.81)     16 (13.79)   0.091            n.s.
  Bronchial asthma                                                 9 (1.32)                       4 (3.45)                        0.095            n.s.                                           52 (7.64)     15 (12.93)   0.057            n.s.
  Allergic nasal catarrh                                           31 (4.55)                      2 (1.72)                        0.158            n.s.                                           109 (16.01)   36 (31.03)   1.05 × 10^−4^    [\*\*](#bem21987-note-0035){ref-type="fn"}
  Allergic conjunctivitis                                          12 (1.76)                      2 (1.72)                        0.977            n.s.                                           59 (8.66)     28 (24.14)   7.80 × 10^−7^    [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Rash                                                             8 (1.17)                       0 (0.00)                        0.241            n.s.                                           69 (10.13)    25 (21.55)   4.24 × 10^−4^    [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Hey fever                                                        44 (6.46)                      4 (3.45)                        0.207            n.s.                                           123 (18.06)   39 (33.62)   1.19 × 10^−4^    [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Food allergies                                                   5 (0.73)                       5 (4.31)                        0.001            n.s.                                           46 (6.75)     24 (20.69)   9.52 × 10^−7^    [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Other allergy symptom[^b^](#bem21987-note-0033){ref-type="fn"}   0 (0.00)                       2 (1.72)                        6.02 × 10^−4^    [\*](#bem21987-note-0034){ref-type="fn"}       33 (4.85)     9 (7.76)     0.194            n.s.
  Sick house syndrome                                              0 (0.00)                       4 (3.45)                        1.19 × 10^−6^    [\*\*\*](#bem21987-note-0036){ref-type="fn"}   8 (1.17)      23 (19.83)   7.64 × 10^−22^   [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Multiple chemical sensitivity                                    0 (0.00)                       46 (39.66)                      2.75 × 10^−64^   [\*\*\*](#bem21987-note-0036){ref-type="fn"}   7 (1.03)      19 (16.38)   7.74 × 10^−18^   [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Electromagnetic hypersensitivity                                 0 (0.00)                       46 (39.66)                      2.75 × 10^−64^   [\*\*\*](#bem21987-note-0036){ref-type="fn"}   1 (0.15)      19 (16.38)   5.04 × 10^−25^   [\*\*\*](#bem21987-note-0036){ref-type="fn"}
  Others                                                           7 (1.03)                       9 (7.76)                        1.77 × 10^−6^    [\*\*\*](#bem21987-note-0036){ref-type="fn"}   42 (6.17)     41 (35.34)   1.90 × 10^−21^   [\*\*\*](#bem21987-note-0036){ref-type="fn"}

Note: Differences in prevalence of chronic illnesses between self‐selected EHS subjects (*n* = 116) and controls (*n* = 681) were analyzed using *χ* ^2^ test with Bonferroni correction for multiple tests (40 tests; *P* \< 0.000125). n.s.: not significant.

Allergy symptoms: percentage for "Allergy symptoms" does not represent the sum of percentages from "Atopic dermatitis" to "Other allergy symptoms" because some participants described more than one allergy symptom.

Other allergy symptoms: allergy diseases other than those described above.

*P*  ≤  0.0005.

*P*  ≤  0.0001.

*P * ≤  0.00001.

© 2016 Wiley Periodicals, Inc.

It is notable that the proportion of self‐selected EHS subjects who suffered from several allergy symptoms (64.66%) in the past was significantly higher (*P* \< 0.00001) than corresponding proportion of controls (41.85%), as seen in Table [10](#bem21987-tbl-0010){ref-type="table-wrap"}. The proportion of patients whose symptoms were diagnosed as autonomic imbalance, allergy nasal catarrh, allergy conjunctivitis, rash, hay fever, food allergies, and other allergy symptoms in the past was also significantly higher in self‐selected EHS subjects than in controls. However, there was no significant difference in the proportion of patients diagnosed with diabetes mellitus, high blood pressure, heart disease, migraine, atopic dermatitis, and bronchial asthma between the two groups (Table [10](#bem21987-tbl-0010){ref-type="table-wrap"}).

Sequence of EHS Development Estimated by Self‐Selected EHS Subjects {#bem21987-sec-0032}
-------------------------------------------------------------------

A summary of the estimated progression of symptoms by self‐selected EHS subjects is shown in Figure [3](#bem21987-fig-0003){ref-type="fig"}. Our study revealed that EHS was present in only 18.52% of self‐selected EHS subjects, with a majority (81.52%) of self‐selected EHS subjects having presented with both MCS and EHS symptoms. In half of such self‐selected EHS subjects SHS or MCS symptoms occurred before EHS symptoms, whereas a relatively small proportion of self‐selected EHS subjects (14.81%) presented with EHS symptoms were subsequently followed by MCS symptoms.

![Speculated sequence of onset of SHS, MCS, and EHS by Japanese self‐selected EHS subjects. SHS: sick house syndrome; MCS: multiple chemical sensitivity; EHS: electromagnetic hypersensitivity. ^a^Both MCS and EHS were associated; however, it is unknown which occurred first.](BEM-37-353-g003){#bem21987-fig-0003}

Responses to Open Question of How the Individual Has Been Suffering From EHS Syndrome {#bem21987-sec-0033}
-------------------------------------------------------------------------------------

Most self‐selected EHS subjects described their symptoms in detail. Furthermore, many of them expressed facing financial difficulties following resignations due to sickness, and their concern regarding a lack of understanding about EHS by general physicians and the public. Firstly, self‐selected EHS subjects stated there were few physicians who had profound knowledge of both MCS and EHS. Secondly, they claimed that they were treated for diseases with various names based on their symptoms but to no avail; moreover, they were even forced to change hospitals several times. Thirdly, their symptoms were diagnosed as mental disorders, resulting in strained family relationships.

DISCUSSION {#bem21987-sec-0034}
==========

The reliability of the Japanese EHS questionnaire was confirmed by high to moderate ICC values (0.623--0.863) obtained for all 5‐point scale questions and total scores of each subscale, with the exception of four items (component 4, q64, q65, and q71) in the test--retest analysis (Table [4](#bem21987-tbl-0004){ref-type="table-wrap"}). In addition, high Cronbach\'s *α* coefficients (0.853--0.953) from all subscales, with the exception of "Reaction to EMFs (0.528)," indicated good internal consistency for each question (Table [5](#bem21987-tbl-0005){ref-type="table-wrap"}).

The validity of the Japanese EHS Questionnaire was confirmed by observing significant differences (*P* \< 0.0005) in all scorers, with the exception of two items (q69 and q70) between self‐selected EHS subjects, and age‐ and sex‐matched controls, using simple logistic regression analysis (Table [7](#bem21987-tbl-0007){ref-type="table-wrap"}). ORs for q68 (90.96) and q67 (9.66) were extremely high, indicating the high discriminatory power of these two questions in the screening of EHS individuals from the general public. Similarly, the OR of the total symptom score, which was used as the main criterion, was also found to be significantly high (OR; 1.05, *P* = 6.78 × 10^−4^). In addition, significantly high ORs were observed for all nine EMF‐producing objects, especially electrical appliances (OR: 4.29), telecommunication masts (OR: 3.87), and fluorescent lighting (OR: 3.60), and for the total score for EMF‐producing objects in this study (OR: 2.61*--*4.29). Thus, these three items may be considered to be the primary EMF‐producing objects believed by self‐selected EHS subjects in Japan to be the cause of symptom onset; further studies exploring this are warranted.

Results of Mann--Whitney *U*‐ and *χ* ^2^ tests also indicated that, compared to controls, self‐selected EHS subjects reported a greater severity of symptoms, poorer levels of general health and well‐being, and a belief that their symptoms were due to exposure to objects that emit EMFs (Table [6](#bem21987-tbl-0006){ref-type="table-wrap"}). These results were consistent with those reported by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\], who used the same tests (Mann--Whitney *U*‐ and *χ* ^2^ tests) in their UK‐based study. The extreme statistical significances shown in Table [6](#bem21987-tbl-0006){ref-type="table-wrap"} arose from the selection process: the EHS subjects already shared these beliefs, while the controls did not even understand the questions.

Characteristics of Symptoms in Japanese Self‐Selected EHS Subjects {#bem21987-sec-0035}
------------------------------------------------------------------

Principal component analysis of 57 symptoms in controls (*n* = 1,306) revealed the following eight main symptom subscales: nervous system, skin, head, auditory and vestibular, musculoskeletal system, allergy, sensory system, and heart/chest (Tables [2](#bem21987-tbl-0002){ref-type="table-wrap"} and [3](#bem21987-tbl-0003){ref-type="table-wrap"}). Findings of the present study are similar to those reported by Kato and Johansson \[[2012](#bem21987-bib-0021){ref-type="ref"}\], who used a different questionnaire and observed that major subjective symptoms developed by Japanese self‐selected EHS subjects included fatigue/tiredness, headache, and difficulty in concentrating, remembering, and thinking. In the study by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\], an eight‐factor principal components analysis of symptoms in the English general population resulted in eight symptom subscales: neurovegetative, skin, auditory, headache, cardiorespiratory, cold‐related, locomotor, and allergy‐related symptoms; these findings are similar to those observed in the present study. Nordin et al. \[[2013](#bem21987-bib-0029){ref-type="ref"}\] conducted an exploratory principal component analysis and reported that symptoms of EHS individuals in Sweden could be divided into five significant groups: airway symptoms, skin and eye symptoms, cardiac, dizziness and nausea, and cognitive and affective symptoms. As described in WHO fact sheet 296 \[WHO, [2005](#bem21987-bib-0038){ref-type="ref"}\], EHS is characterized by a variety of non‐specific symptoms, which are attributed to EMF exposure by afflicted individuals. Symptoms most commonly experienced included dermatological symptoms (redness, tingling, and burning sensation) as well as neurasthenia and vegetative symptoms (fatigue, tiredness, concentration difficulties, dizziness, nausea, heart palpitations, and digestive disturbances). Hence, taking these factors into consideration, we assumed that the main symptoms of self‐selected EHS subjects in Japan could be evaluated using eight symptom categories described in previous studies conducted in Europe.

Relationship Between EHS and Other Chronic Illnesses (IV--3 Additional Questions) {#bem21987-sec-0036}
---------------------------------------------------------------------------------

Close relationships between allergy symptoms and MCS/EHS are often observed in clinical practice \[Rea et al., [1991](#bem21987-bib-0031){ref-type="ref"}\]. However, so far, few reports exist describing the relationship between MCS/EHS and chronic illness, including allergy symptoms. Findings of the present study (Table [9](#bem21987-tbl-0009){ref-type="table-wrap"}) are new and are suggestive of a close relationship between MCS/EHS and allergy symptoms. Nevertheless, further studies are required to investigate underlying mechanisms responsible for this close relationship. The Japanese EHS questionnaire can be used as an effective tool to analyze the relationship between MCS/EHS and allergy symptoms, and to determine effective, future treatment modalities for MCS/EHS patients.

EMF Sources Believed by Japanese Self‐Selected EHS Subjects as Cause of Their Symptoms {#bem21987-sec-0037}
--------------------------------------------------------------------------------------

Similar to the study conducted in the UK, we found nine types of EMF sources (computers, electrical appliances, fluorescent lighting, microwave ovens, mobile phones, power lines, radio/television transmitters, telecommunication masts, and televisions), which Japanese self‐selected EHS subjects considered as the cause of their symptoms in the present study. Interestingly, the following EMF sources were selected by the majority of Japanese self‐selected EHS subjects: electric appliances, followed by mobile phones, computers, and telecommunication masts (Fig. [2](#bem21987-fig-0002){ref-type="fig"}). Furthermore, besides the aforementioned nine sources in the questionnaire, several new types of EMF sources, including those used for transportation (e.g., cars, buses, Shinkansen), communication devices other than mobile phones (e.g., wireless LAN, Wi‐Fi, security equipment), and medical devices (MRI, X‐rays, dental therapeutic instrument) were also nominated by self‐selected EHS subjects. Hence, we believe that these new EMF sources should be added to the Japanese version of EHS questionnaires in future surveys.

Work Style and Relationship With MCS {#bem21987-sec-0038}
------------------------------------

Consistent with results reported by Kato and Johansson \[[2012](#bem21987-bib-0021){ref-type="ref"}\] in Japan and Hillert et al. \[[2002](#bem21987-bib-0009){ref-type="ref"}\] in Sweden, the number of full‐time workers was significantly lower, whereas the number of unemployed persons and part‐time workers was significantly higher among self‐selected EHS subjects when compared with controls in the present study (Table [1](#bem21987-tbl-0001){ref-type="table-wrap"}).

EHS resembles MCS, another disorder associated with low‐level environmental exposure to chemicals, because both EHS and MCS are characterized by a range of non‐specific symptoms that lack an apparent toxicological and physiological basis and/or independent verification \[WHO, [2005](#bem21987-bib-0038){ref-type="ref"}\]. Rea et al. \[[1991](#bem21987-bib-0031){ref-type="ref"}\] reported that more than 80% of EHS patients presented with MCS. The results of the present study (Fig. [3](#bem21987-fig-0003){ref-type="fig"}) are consistent with those of Rea et al. \[[1991](#bem21987-bib-0031){ref-type="ref"}\].

Proposal of Preliminary Criteria for Screening Japanese EHS Individuals {#bem21987-sec-0039}
-----------------------------------------------------------------------

Based on the results of multiple logistic regression and ROC analyses in the present study, we propose the following preliminary criteria for the screening of Japanese EHS individuals: (1) the total symptom score should be greater than, or equal to, 47 points (75th percentile of controls, Fig [1](#bem21987-fig-0001){ref-type="fig"}a); (2) the score for q67 ("Are you sensitive to electromagnetic fields?") should be greater than, or equal to, 1; and (3) individuals should be able to describe the EMF source and the kind of symptoms developed in detail in response to q68.

Preliminary criteria suggested by the present study for the screening of EHS individuals in the general population are similar to those proposed by Eltiti et al. \[[2007](#bem21987-bib-0007){ref-type="ref"}\]. However, the 75th percentile for controls was 26 points in the UK, and 47 points in Japan. Eighty‐two (64.6%) of the 127 self‐selected EHS subjects met with set screening criteria for EHS individuals. Furthermore, 60 subjects from the controls (1,306 respondents out of 2,000) also met with these preliminary screening criteria, suggesting that 3.0--4.6% of the general public in Japan may be EHS individuals, even though none are currently diagnosed with SHS or MCS /EHS. In addition, significant differences were not observed in all scores between 60 subjects from the control group and self‐selected EHS subjects (data not shown).

Based on the fact that only 1% of the population of Japan is aware of EHS, determined by a preliminary survey \[Hojo and Tokiya, [2012](#bem21987-bib-0018){ref-type="ref"}\], some of these 60 subjects may have some knowledge of EHS; however, the majority of them most probably have no knowledge of this condition. Thus, it is very important that these unsuspecting individuals, who may have developed EHS symptoms, visit a qualified medical specialist. However, it is worthy to note that in response to the open question on the last page of the questionnaire ("Please provide a detailed description of how you have been suffering from EHS syndromes," Supplementary Materials), many self‐selected EHS subjects described how only a few medical doctors had professional knowledge of EHS/MCS, and most were generally incompetent with regards to the treatment of this condition in Japan. Consequently, Japanese self‐selected EHS subjects have suffered greatly in their day‐to‐day life \[Ito et al., [2012](#bem21987-bib-0020){ref-type="ref"}\], making it imperative to have specialists who are familiar with EHS, as well as MCS and SHS.

Future Directions {#bem21987-sec-0040}
-----------------

As stated in the COST fact sheet \[COST, [2011](#bem21987-bib-0005){ref-type="ref"}\], individuals who think they are sensitive to EMF actually feel symptoms; therefore, it is important to endeavor to improve, and to understand the mechanisms and causal relations associated with their condition. The limitation of this study is that this is one of the descriptive survey findings for perceptions of causation in a self‐selected group who believes EMF is a cause of their symptoms. Thus, systematic approaches, including the provision of information, support for patients with symptoms of earlier stages, and treatment for persons with prolonged and severe symptoms, are required. We believe that it is time to develop and initiate a systematic approach, wherein the provision of information about EHS to general physicians and the public is mandatory in Japan. The Japanese EHS questionnaire can be used as an effective tool for providing such information.

The COST fact sheet also states that "the choice of treatment should be based on a broad evaluation of the patient\'s symptoms and situation (including medical, psychosocial, and environmental aspects) and taking the patient\'s motivation for different interventions into account. Cognitive therapy has been reported to improve well‐being and the ability to cope with persisting symptoms in some patients." We agree that multi‐faceted therapies are useful for the treatment of EHS individuals with severe and long‐lasting symptoms, and believe the Japanese EHS Questionnaire will be useful in evaluating such therapies.

CONCLUSION {#bem21987-sec-0041}
==========

The Japanese EHS questionnaire is highly reliable and valid, and can be used to screen EHS individuals from the general population in Japan. This questionnaire can be used to elucidate the actual status of EHS individuals in Japan, to evaluate the effects of therapies or lifestyle changes in people presenting with EHS‐related symptoms, and as a cross‐comparison of groups studied by different investigators.

Supporting information
======================

Additional supporting information may be found in the online version of this article at the publisher\'s website.
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**Table S1**. Comparison of question style between original (left) and Japanese (right) EHS questionnaires in II‐I symptoms.

###### 

Click here for additional data file.
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